Green Synthesis of Zinc Oxide Nanoparticles Using Extracts: Unveiling Bioactive Compounds, Antibacterial Potential, and Antioxidant Activities.

Waheeda Mushtaq, Muhammad Ishtiaq, Mehwish Maqbool, Muhammad Waqas Mazhar, Ryan Casini, Ahmed M Abd-ElGawad, Hosam O Elansary
Author Information
  1. Waheeda Mushtaq: Department of Botany, Mirpur University of Science & Technology (MUST), Mirpur 10250, Pakistan.
  2. Muhammad Ishtiaq: Department of Botany, Mirpur University of Science & Technology (MUST), Mirpur 10250, Pakistan. ORCID
  3. Mehwish Maqbool: Department of Botany, Mirpur University of Science & Technology (MUST), Mirpur 10250, Pakistan.
  4. Muhammad Waqas Mazhar: Department of Botany, Mirpur University of Science & Technology (MUST), Mirpur 10250, Pakistan. ORCID
  5. Ryan Casini: School of Public Health, University of California, Berkeley, 2121 Berkeley Way, Berkeley, CA 94704, USA.
  6. Ahmed M Abd-ElGawad: Department of Plant Production, College of Food & Agriculture Sciences, King Saud University, P.O. Box 2460, Riyadh 11451, Saudi Arabia. ORCID
  7. Hosam O Elansary: Department of Plant Production, College of Food & Agriculture Sciences, King Saud University, P.O. Box 2460, Riyadh 11451, Saudi Arabia. ORCID

Abstract

The current study explored the antioxidant and antibacterial capabilities of zinc oxide nanoparticles (ZnONPs) synthetized using methanolic leaf extracts of the medicinal herb . Through TEM investigation and UV-Vis analysis, which peaked at 406 nm, the synthesis of ZnONPs was verified. TEM analyses showed that the synthesized ZnONPs had a size distribution with an average of 13.5 nm and a quasi-spherical shape. Forty-four phytoconstituents were found in the methanolic leaf extracts of . Additionally, a comparison of the antibacterial effectiveness and antioxidant capacity of aqueous and methanolic extracts of wild-grown phytomedicine and green-manufactured ZnONPs was conducted. The green-generated ZnONPs were examined against , , and and shown to have superior antibacterial activity by 22%, 66%, and 44%, respectively, as compared to wild herbal medicinal extracts. Since the ZnONPs' aqueous extracts had higher concentrations of DNA gyrase-B inhibitory components, they were shown to be more effective in limiting bacterial growth. In contrast to the percentages of 49% and 57% for a wild plant extract, the aqueous- and methanolic-extract-mediated green ZnONPs, with a 100 g/mL concentration, showed 94% and 98% scavenging capacity for DPPH free radicals, respectively. However, methanolic extracts were more effective than aqueous extracts in terms of the antioxidant analyses. This study establishes that greenly produced ZnONPs have the potential to be used in nanomedicine to treat bacteria that are resistant to a variety of drugs, as well as those with reactive oxygen species toxicity.

Keywords

References

  1. Anal Bioanal Chem. 2022 Jan;414(1):515-524 [PMID: 34173037]
  2. Int J Biol Macromol. 2022 Nov 30;221:665-678 [PMID: 36089092]
  3. Nature. 2019 Jan;565(7738):234-239 [PMID: 30568305]
  4. Environ Sci Pollut Res Int. 2022 Jan;29(4):5006-5031 [PMID: 34811612]
  5. J Hazard Mater. 2022 Feb 5;423(Pt A):126958 [PMID: 34464859]
  6. Molecules. 2021 Mar 25;26(7): [PMID: 33805867]
  7. PLoS One. 2021 Jan 13;16(1):e0243151 [PMID: 33439877]
  8. J Biomed Mater Res A. 2022 Feb;110(2):424-442 [PMID: 34331516]
  9. PLoS One. 2021 Jul 29;16(7):e0255010 [PMID: 34324561]
  10. Phytochemistry. 2014 Jun;102:7-39 [PMID: 24661611]
  11. ChemMedChem. 2018 Jan 22;13(2):186-198 [PMID: 29206345]
  12. Nanomaterials (Basel). 2021 Mar 03;11(3): [PMID: 33802496]
  13. J Hazard Mater. 2021 Jan 15;402:123560 [PMID: 32759001]
  14. Antibiotics (Basel). 2021 Aug 12;10(8): [PMID: 34439019]
  15. Nanoscale Res Lett. 2018 May 8;13(1):141 [PMID: 29740719]
  16. Biotechnol Rep (Amst). 2020 Jan 31;25:e00427 [PMID: 32055457]
  17. J Infect Public Health. 2017 Jul - Aug;10(4):369-378 [PMID: 27616769]
  18. J Ethnopharmacol. 2021 Sep 15;277:114233 [PMID: 34044077]
  19. Saudi Pharm J. 2018 Mar;26(3):311-322 [PMID: 29556122]
  20. PeerJ. 2020 Aug 26;8:e9769 [PMID: 32913677]
  21. PLoS One. 2022 Mar 24;17(3):e0264967 [PMID: 35324949]
  22. Inflammopharmacology. 2020 Apr;28(2):563-574 [PMID: 31792766]
  23. Animals (Basel). 2022 Aug 25;12(17): [PMID: 36077907]
  24. Food Chem Toxicol. 2018 Nov;121:82-94 [PMID: 30130593]
  25. Food Sci Nutr. 2019 Jan 28;7(2):779-787 [PMID: 30847157]
  26. Antibiotics (Basel). 2020 Aug 04;9(8): [PMID: 32759771]
  27. Microbiol Mol Biol Rev. 2011 Mar;75(1):133-91 [PMID: 21372322]
  28. Sci Rep. 2018 Aug 27;8(1):12839 [PMID: 30150658]
  29. Plants (Basel). 2022 Sep 23;11(19): [PMID: 36235358]
  30. Pharmacogn Rev. 2010 Jul;4(8):118-26 [PMID: 22228951]

Grants

  1. RSPD2023R676/Researchers Supporting Project number (RSPD2023R676), King Saud University.